Selective Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-312
Closed -$232K 108
2024
Q4
$232K Sell
312
-3
-1% -$2.48K 0.09% 94
2024
Q3
$288K Hold
315
0.12% 87
2024
Q2
$294K Sell
315
-16
-5% -$12.8K 0.13% 84
2024
Q1
$252K Buy
+331
New +$236K 0.11% 92
2022
Q4
Sell
-116
Closed -$38K 462
2022
Q3
$38K Sell
116
-200
-63% -$63.4K 0.02% 330
2022
Q2
$102K Buy
316
+200
+172% +$60K 0.04% 216
2022
Q1
$33K Buy
+116
New +$29.9K 0.01% 378
2021
Q4
Sell
-116
Closed -$27K 683
2021
Q3
$27K Hold
116
0.01% 336
2021
Q2
$27K Sell
116
-50
-30% -$10K 0.02% 253
2021
Q1
$31K Buy
166
+50
+43% +$9.78K 0.03% 159
2020
Q4
$20K Hold
116
0.01% 185
2020
Q3
$17K Sell
116
-111
-49% -$17.2K 0.01% 168
2020
Q2
$37K Hold
227
0.03% 127
2020
Q1
$31K Hold
227
0.05% 81
2019
Q4
$30K Hold
227
0.04% 93
2019
Q3
$25K Buy
+227
New +$25.3K 0.03% 107
2018
Q3
$12K Buy
+116
New +$11.6K 0.14% 77

Other funds holding LLY

Selective Wealth Management's LLY Position: Q1 2025 in Review

Selective Wealth Management sold out of Eli Lilly (LLY) in Q1 2025, closing a stake of 312 shares — an estimated $232K sold.

Selective Wealth Management first reported a position in LLY in Q3 2018 and held it in 17 quarters. The position peaked at $294K in Q2 2024. 3,919 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

  • Selective Wealth Management reported no remaining Eli Lilly position as of Q1 2025 after selling out during the quarter.
  • Selective Wealth Management sold 312 Eli Lilly shares in Q1 2025, an estimated $232K.
  • Selective Wealth Management first reported a position in Eli Lilly in Q3 2018 and held it in 17 quarters.
  • Selective Wealth Management's Eli Lilly position peaked at $294K in Q2 2024.
  • 3,919 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on Selective Wealth Management's 13F filing for Q1 2025, filed 14 Apr 2025.